These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Possibilities and limitations in the diagnosis and therapy of peripheral arterial circulatory disorders in ambulatory practice]. Kamp O. Z Arztl Fortbild (Jena); 1977 Feb 01; 71(3):126-31. PubMed ID: 848061 [No Abstract] [Full Text] [Related]
10. [Guidelines for the evaluation of the therapeutic effects of peripheral vasoactive drugs in arterial occlusive disease]. Adank K, Barras JP, Biland L, Bollinger A, Galeazzi R, Kämpf R, Mirimanoff P, Schelling JL, Widmer LK. Vasa; 1981 Feb 01; 10(4):337-41. PubMed ID: 7032111 [No Abstract] [Full Text] [Related]
11. [Drug therapy of peripheral arterial occlusive disease]. Mahler F. Schweiz Med Wochenschr; 1981 May 02; 111(18):637-40. PubMed ID: 7244587 [Abstract] [Full Text] [Related]
12. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Int Angiol; 2000 Mar 02; 19(1 Suppl 1):I-XXIV, 1-304. PubMed ID: 10855444 [No Abstract] [Full Text] [Related]
13. [The therapeutic effects of flunarizine in peripheral arterial diseases and cerebrovascular diseases]. De Gregorio G, Restivo S. Clin Ter; 1982 Dec 15; 103(5):501-7. PubMed ID: 7160142 [No Abstract] [Full Text] [Related]
14. [Modern conservative therapy of arterial occlusive diseases]. Schultz-Ehrenburg U. Hautarzt; 1980 Aug 15; 31(8):419-27. PubMed ID: 7451147 [Abstract] [Full Text] [Related]
15. [Practice guideline--peripheral arterial occlusive disease. Drug Committee of the German Medical Association]. Z Arztl Fortbild Qualitatssich; 1997 Jul 15; 91(4):385-7. PubMed ID: 9340210 [No Abstract] [Full Text] [Related]
16. [Evaluation of the combined use of Nico-padutin forte and depot-Padutin in peripheral arterial occlusive disease]. Hoffmann J. Med Welt; 1982 Jul 16; 33(28):1034-7. PubMed ID: 6922390 [No Abstract] [Full Text] [Related]
18. Essentials in the diagnosis and management of peripheral arterial disease. Medina-Ruiz A, Sánchez-Vélez ME. P R Health Sci J; 2004 Dec 16; 23(4):313-8. PubMed ID: 15776695 [Abstract] [Full Text] [Related]
19. [Prostaglandins including prostacyclin in the treatment of peripheral arterial occlusive disorders]. Alexander K. Internist (Berl); 1989 Jul 16; 30(7):429-39. PubMed ID: 2670810 [No Abstract] [Full Text] [Related]
20. [Principles of pathogenetic treatment of patients with obliterating arterial diseases of the extremities]. Mizun PG. Sov Med; 1973 Oct 16; 36(10):18-23. PubMed ID: 4789211 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]